A detailed history of New York State Common Retirement Fund transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 33,958 shares of ADPT stock, worth $216,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,958
Previous 33,958 -0.0%
Holding current value
$216,991
Previous $123,000 41.46%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$2.34 - $3.96 $189 - $320
81 Added 0.24%
33,958 $123,000
Q1 2024

May 07, 2024

SELL
$2.88 - $4.8 $403 - $672
-140 Reduced 0.41%
33,877 $109,000
Q4 2023

Feb 01, 2024

SELL
$3.46 - $5.33 $35,911 - $55,320
-10,379 Reduced 23.38%
34,017 $167,000
Q3 2023

Nov 07, 2023

BUY
$5.07 - $8.44 $1,688 - $2,810
333 Added 0.76%
44,396 $242,000
Q2 2023

Aug 07, 2023

SELL
$6.19 - $8.78 $74,422 - $105,561
-12,023 Reduced 21.44%
44,063 $296,000
Q1 2023

May 02, 2023

SELL
$7.8 - $10.11 $174,135 - $225,705
-22,325 Reduced 28.47%
56,086 $495,000
Q4 2022

Jan 30, 2023

SELL
$6.26 - $9.34 $319 - $476
-51 Reduced 0.06%
78,411 $599,000
Q3 2022

Nov 08, 2022

BUY
$6.5 - $12.67 $6,084 - $11,859
936 Added 1.21%
78,462 $559,000
Q2 2022

Aug 04, 2022

SELL
$6.4 - $14.73 $215,744 - $496,548
-33,710 Reduced 30.3%
77,526 $627,000
Q1 2022

May 05, 2022

SELL
$10.12 - $28.9 $116,379 - $332,350
-11,500 Reduced 9.37%
111,236 $1.54 Million
Q2 2021

Aug 02, 2021

SELL
$32.22 - $44.59 $193,577 - $267,896
-6,008 Reduced 4.67%
122,736 $5.02 Million
Q1 2021

May 11, 2021

SELL
$37.26 - $67.74 $3.08 Million - $5.61 Million
-82,762 Reduced 39.13%
128,744 $5.18 Million
Q4 2020

Feb 08, 2021

SELL
$45.01 - $65.47 $441,098 - $641,606
-9,800 Reduced 4.43%
211,506 $12.5 Million
Q3 2020

Nov 05, 2020

SELL
$35.79 - $48.81 $196,845 - $268,455
-5,500 Reduced 2.42%
221,306 $10.8 Million
Q2 2020

Aug 07, 2020

BUY
$24.95 - $48.38 $2.14 Million - $4.14 Million
85,600 Added 60.62%
226,806 $11 Million
Q1 2020

May 06, 2020

BUY
$16.96 - $34.16 $1.89 Million - $3.8 Million
111,370 Added 373.27%
141,206 $3.92 Million
Q4 2019

Feb 05, 2020

BUY
$24.56 - $32.8 $395,416 - $528,080
16,100 Added 117.21%
29,836 $893,000
Q3 2019

Nov 07, 2019

BUY
$30.31 - $53.51 $414,822 - $732,337
13,686 Added 27372.0%
13,736 $424,000
Q2 2019

Aug 09, 2019

BUY
$40.3 - $48.3 $2,014 - $2,415
50 New
50 $2,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $913M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.